{
    "applicationNumber": "BR 11 2021 007995-5",
    "filingDate": "01/11/2019",
    "grantDate": null,
    "title": "MOL\u00c9CULA DE ANTICORPO ANTAGONISTA, SEQU\u00caNCIA DE NUCLEOT\u00cdDEOS ISOLADA, PLASM\u00cdDEO, V\u00cdRUS, C\u00c9LULA, USO DE UMA MOL\u00c9CULA DE ANTICORPO, COMPOSI\u00c7\u00c3O FARMAC\u00caUTICA, M\u00c9TODO PARA TRATAR C\u00c2NCER OU UMA INFEC\u00c7\u00c3O CAUSADA POR UM PAT\u00d3GENO INTRACELULAR EM UM PACIENTE",
    "nationalPhaseDate": [
        "27/04/2021"
    ],
    "internationalApplication": {
        "pctNumber": "PCT EP2019/080004",
        "pctDate": "01/11/2019",
        "wipoNumber": null,
        "wipoDate": null
    },
    "priorityClaims": [
        {
            "countryCode": "EP",
            "priorityNumber": "18203993.3",
            "priorityDate": "01/11/2018"
        }
    ],
    "events": [
        {
            "code": "1.1",
            "description": "Publica\u00e7\u00e3o Internacional \u2013 PCT. Apresenta\u00e7\u00e3o de peti\u00e7\u00e3o de requerimento de entrada na fase nacional",
            "bulletinNumber ": "2626"
        },
        {
            "code": "1.3",
            "description": "Notifica\u00e7\u00e3o - Fase Nacional - PCT",
            "bulletinNumber ": "2640"
        }
    ],
    "inventors": [
        "BJ\u00d6RN FRENDEUS",
        "INGRID TEIGE",
        "LINDA M\u00c5RTENSSON",
        "PETRA HOLMKVIST",
        "MONIKA SEMMRICH"
    ],
    "holders": [
        268753
    ],
    "ipcCodes": [
        "A61P 31/00",
        "A61K 39/00",
        "C07K 16/28"
    ]
}